(MedPage Today) — The FDA approved oveporexton (Orzeyful) for the treatment of narcolepsy type 1 (narcolepsy with cataplexy) in adults, the agency announced Wednesday.
Oveporexton is a first-in-class orexin treatment that goes beyond symptom…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
